Distribution of Plasma One-Carbon Metabolism Factors and Amino Acids Profile in Depression State Treated with Paroxetine: A Model Study.

Amino acid Depression Mice Selective serotonin reuptake inhibitor

Journal

Cell journal
ISSN: 2228-5806
Titre abrégé: Cell J
Pays: Iran
ID NLM: 101566618

Informations de publication

Date de publication:
07 Mar 2023
Historique:
received: 10 07 2022
medline: 12 4 2023
entrez: 11 4 2023
pubmed: 12 4 2023
Statut: epublish

Résumé

Stress may have an important role in the origin and progress of depression and can impair metabolic homeostasis. The one-carbon cycle (1-CC) metabolism and amino acid (AA) profile are some of the consequences related to stress. In this study, we investigated the Paroxetine treatment effect on the plasma metabolite alterations induced by forced swim stress-induced depression in mice. In this experimental study that was carried out in 2021, thirty male NMRI mice (6-8 weeks age, 30 ± 5 g) were divided into five groups: control, sham, paroxetine treatment only (7 mg/kg BW/day), depression induction, and Paroxetine+depression. Mice were subjected to a forced swim test (FST) to induce depression and then were treated with Paroxetine, for 35 consecutive days. The swimming and immobility times were recorded during the interventions. Then, animals were sacrificed, plasma was prepared and the concentration of 1-CC factors and twenty AAs was measured by spectrophotometry and high-performance liquid chromatography system (HPLC) techniques. Data were analyzed by SPSS, using One-Way ANOVA and Pearson Correlation, and P<0.05 was considered significant. Plasma concentrations of phenylalanine, glutamate, aspartate, arginine, ornithine, citrulline, threonine, histidine, and alanine were significantly reduced in the depression group in comparison with the control group. The Homocysteine (Hcy) plasma level was increased in the Paroxetine group which can be associated with hyperhomocysteinemia. Moreover, vitamin B12, phenylalanine, glutamate, ornithine, citrulline, and glycine plasma levels were significantly reduced in the depression group after Paroxetine treatment. This study has demonstrated an impairment in the plasma metabolites' homeostasis in depression and normal conditions after Paroxetine treatment, although, further studies are required.

Identifiants

pubmed: 37038696
doi: 10.22074/cellj.2023.557498.1056
pmc: PMC10105297
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

165-175

Références

J Affect Disord. 2012 Oct;140(2):187-92
pubmed: 22424639
Sci Rep. 2016 Oct 12;6:35317
pubmed: 27731396
Psychopharmacology (Berl). 2017 Nov;234(21):3241-3247
pubmed: 28803324
Nutrients. 2020 Sep 19;12(9):
pubmed: 32961717
Korean J Physiol Pharmacol. 2014 Oct;18(5):371-6
pubmed: 25352755
J Acupunct Meridian Stud. 2017 Jan;10(1):26-32
pubmed: 28254098
Medicine (Baltimore). 2020 Jul 02;99(27):e21068
pubmed: 32629736
PLoS One. 2016 Aug 04;11(8):e0160542
pubmed: 27490818
Biosci Biotechnol Biochem. 2008 Jul;72(7):1940-3
pubmed: 18603771
J Psychiatr Res. 2018 Jan;96:23-32
pubmed: 28950111
Transl Psychiatry. 2011 Dec 13;1:e58
pubmed: 22832350
Eur J Pharmacol. 2008 Oct 10;594(1-3):117-24
pubmed: 18691569
J Clin Psychiatry. 1992 Feb;53 Suppl:21-6
pubmed: 1531817
Psychopharmacology (Berl). 2018 Oct;235(10):3017-3030
pubmed: 30116859
World J Biol Psychiatry. 2021 Apr;22(4):315-321
pubmed: 32787676
Sci Rep. 2019 Feb 26;9(1):2811
pubmed: 30808966
J Ren Nutr. 1998 Jan;8(1):34-9
pubmed: 9724828
Br J Psychiatry. 2014 Dec;205(6):450-7
pubmed: 25257064
Psychopharmacol Bull. 1996;32(4):653-8
pubmed: 8993087
Psychiatry Res. 2012 Dec 30;200(2-3):1054-7
pubmed: 22749229
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1155-8
pubmed: 16707201
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2649-56
pubmed: 16085680
J Vis Exp. 2015 Mar 02;(97):
pubmed: 25867960
Acta Psychiatr Scand. 1998 Apr;97(4):302-8
pubmed: 9570492
BMC Psychiatry. 2020 Jun 24;20(1):333
pubmed: 32580709
J Affect Disord. 2018 Mar 15;229:145-151
pubmed: 29310063
Transl Psychiatry. 2021 Mar 2;11(1):153
pubmed: 33654056
Pol J Pharmacol. 2000 Nov-Dec;52(6):441-8
pubmed: 11334237
Int J Mol Sci. 2021 Feb 07;22(4):
pubmed: 33562229
BMC Psychiatry. 2020 Feb 13;20(1):63
pubmed: 32054533
Transl Psychiatry. 2017 Apr 4;7(4):e1078
pubmed: 28375208
J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):228-32
pubmed: 10896698
J Psychiatry Neurosci. 2007 Mar;32(2):80-2
pubmed: 17353937
PLoS One. 2012;7(5):e37916
pubmed: 22666412
Sci Rep. 2017 Aug 17;7(1):8631
pubmed: 28819255
Br J Pharmacol. 2003 Nov;140(6):1128-36
pubmed: 14530210
Int J Environ Res Public Health. 2022 Sep 19;19(18):
pubmed: 36142069
CNS Neurosci Ther. 2015 May;21(5):417-24
pubmed: 25611566

Auteurs

Reyhaneh Aghajani (R)

Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.

Nushin Naderi (N)

Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.

Niloofar Sadeghi (N)

Department of Biochemistry and Functional Genomics, University de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.

Mohsen Ani (M)

Department of Clinical Biochemistry, Isfahan University of Medical Sciences, Isfahan, Iran.

Sima Ani (S)

Department of Psychiatry, Isfahan University of Medical Sciences, Isfahan, Iran.

Mohammad Hossein Nasr-Esfahani (MH)

Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.

Classifications MeSH